Kevin McKernan is a renowned leader in DNA sequencing technology. He led a research team part of the original Human Genome Project and is the founder and Chief Science Officer of Medicinal Genomics, a life sciences company that distributes genetics-based platforms for quality and safety testing of legal cannabis.
Nick and Kevin discussed the Cannabis genome, the genome of Psilocybe cubensis (magic mushrooms); Polymerase Chain Reaction (PCR) technology, how it works, and how it's used for COVID-19 testing; cannabinoids such as cannabidiol (CBD) and recent research indicating their potential anti-SARS-CoV-2 effects; blockchain technology for genomics data; and mRNA vaccines and SARS-CoV-2.
Read the companion article to this episode.
Click here to download audio, watch video, or read show notes & transcripts.
If you enjoy my content and want to further support M&M, please read this.
Genomics, PCR, COVID Testing, mRNA Vaccines, Blockchain Technology, Cannabis & Psilocybin Mushroom Genomes | Kevin McKernan | #58